Michigan Clinical Research Institute is conducting a clinical research study for adults ages 18-65 with Bipolar Disorder who are currently experiencing a major depressive episode (MDE) and are currently taking lithium, valproate, or lamotrigine.
An individual may qualify for the study if they:
- Are 18 to 65 years of age
- Subjects with a diagnosis of bipolar I or II and currently experiencing an MDE
- Subject is currently on treatment with a single mood stabilizer (lithium, valproate, or lamotrigine)
- Meet additional study criteria
Reimbursement for reasonable, out-of-pocket expenses such as travel and accommodations may be available to qualified individuals.
Contact us or fill out the form below so we can reach out to you and move forward with pre-screening questions to assess your overall eligibility.